drugset / Trial / NCT02670304

Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS

NCT02670304

Phase 4 Completed 100 enrolled First Affiliated Hospital, Sun Yat-Sen University
RandomizedParallel-groupDouble-blindPrevention

Summary

Letrozole is one kind of aromatase inhibitors which may have effect on decrease estrogen in luteal phase and inhibit the luteal function of ovary. In 2009, Letrozole was reported as one candidate for the treatment or prevention of ovarian hyperstimulation syndrome.

Timeline

Start
2012-01
Primary completion
2013-07
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule
Subject Letrozole Other / unclassified